Aldersley M A, O'Grady J G
Liver Unit, St James's University Hospital, Leeds, England.
Drugs. 1995 Jan;49(1):83-102. doi: 10.2165/00003495-199549010-00007.
The spectrum of liver disease is extremely wide, with many of the underlying disorders having acute and chronic presentations. Most of the underlying pathogenetic mechanisms are accounted for by autoimmune disease, viral infection and toxic insult. The management strategy of any liver disease is a combination of treating the symptoms and complications that arise, as well as drug therapies relevant to the specific underlying diagnosis. Encephalopathy, ascites, spontaneous bacterial peritonitis, variceal bleeding and pruritus are the main complications at which drug therapy is directed, although in some cases it represents only 1 aspect of the overall management. Drug therapy per se is largely ineffective in acute liver failure with the possible exception of acetylcysteine, but many drugs are used in the management of the constituent components of this complex medical emergency. Treatments for specific liver conditions are expanding, especially in the areas of autoimmune and viral disease. The increasing availability and success of liver transplantation has tended to change the emphasis of management, and it is often not appropriate to exhaust the treatment options before referring the patient for transplantation. A comprehensive review of all liver disease is beyond the scope of this article, but hopefully the important principles of management and commonly occurring clinical decisions are discussed.
肝脏疾病的范围极为广泛,许多潜在病症有急性和慢性表现。大多数潜在的发病机制是由自身免疫性疾病、病毒感染和毒性损伤引起的。任何肝脏疾病的管理策略都是治疗出现的症状和并发症,以及针对特定潜在诊断的药物治疗相结合。脑病、腹水、自发性细菌性腹膜炎、静脉曲张出血和瘙痒是药物治疗所针对的主要并发症,尽管在某些情况下它只是整体管理的一个方面。药物治疗本身在急性肝衰竭中大多无效,乙酰半胱氨酸可能是个例外,但许多药物用于管理这种复杂医疗急症的组成部分。针对特定肝脏疾病的治疗方法正在不断扩展,尤其是在自身免疫性疾病和病毒疾病领域。肝移植的可及性增加且成功率提高,这往往改变了管理的重点,在将患者转介进行移植之前用尽治疗选择通常并不合适。对所有肝脏疾病进行全面综述超出了本文的范围,但希望能讨论管理的重要原则和常见的临床决策。